Next generation PI3 kinase inhibition
19 Apr 2013
Next generation PI3 kinase inhibition
Targeting tumour suppressor genes
Potential novel inhibitor to overcome drug resistance induced by RAF, MEK Inhibitors
Durable survival benefit for thalidomide consolidation in multiple myeloma post ASCT
Myeloma UK
Hot topics at IMW 2013 - interactive discussion
Challenging paradigms in multiple myeloma
Myeloma in Asia
Hot topics at IMW 2013
Epigenetic reprogramming of bone marrow mesenchymal stem cells in multiple myeloma
Whole genome sequencing reveals underlying genetics of multiple myeloma
TIVO 1 study shows tivozanib an option for renal cell carcinoma